The US Centers for Disease Control and Prevention (CDC) reported that drug-resistant bacteria and fungi cause an estimated 10 million infections and nearly 51 000 deaths in the US each year.
The updated Antimicrobial Resistance Threats Report found that infections commonly associated with health care, including Clostridioides difficile, accounted for more than 42 000 deaths and nearly $12 billion in health care costs in 2023. The CDC also identified drug-resistant Neisseria meningitidis as a new serious threat, reflecting concern about rising resistant infections outside of hospitals. Additionally, clinical cases of drug-resistant Candida auris rose from nearly 480 in 2019 to about 6300 in 2024, and some strains are resistant to all 3 available classes of antifungal treatment.
The report noted that many bacterial threats can share resistance genes, which makes infections harder to treat. At the same time, the CDC cited progress against C difficile, which moved from an urgent to serious threat categorization after rates dropped from about 130 cases per 100 000 people in 2018 to about 100 per 100 000 people in 2020. Overall, the update categorized 4 urgent threats, 13 serious threats, and 2 concerning threats, with a watch list of 6 pathogens being monitored.
no comments (yet)